Regarding the establishment of the new organization "Integrated Research Department of Bioanalysis" - Providing comprehensive analytical support from research and development to manufacturing of pharmaceuticals.

Our company (hereinafter referred to as "TRC") has established the "Integrated Bioanalysis Research Department" as of April 1st, by integrating departments responsible for structural analysis, characterization analysis, stability testing, and quality testing, in order to strengthen support for the research and development of diverse biopharmaceuticals represented by antibody drugs, nucleic acid/mRNA drugs, and cell therapies.
Traditionally, TRC has provided analytical support at various stages of drug development, including structural analysis and analytical method development to support drug discovery research, pharmacokinetic analysis under GLP conditions, and stability testing under GMP conditions. However, in response to the recent acceleration and diversification of drug development, we determined that an integrated organization of the existing analytical departments would be effective, leading to the establishment of the new organization.
The Integrated Bioanalysis Research Department brings together staff engaged in analysis at various stages of drug development, providing high-quality analytical services to our customers in a seamless manner. This will enhance the sophistication of analytical techniques for biopharmaceuticals, which are evolving daily, while also strengthening our proposal capabilities to customers and aiming for further service evolution.
Under the fundamental philosophy of "contributing to society with advanced technology," TRC will continue to grow together with our customers through the analytical expertise and quality cultivated over many years, contributing to the life sciences field, including drug development.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration